Feinstein
Merck signs lupus research deal
January 30, 2013Research and Development, Sales and Marketing Feinstein, Merck Serono, SLE
Merck Serono and the Feinstein Institute for Medical Research in New York are to collaborate on antibodies to treat systemic …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
